Determinants of Women’s Drug Use During Pregnancy: Perspectives from a Qualitative Study

• Published in: Maternal and child health journal Vol. 24; no. 9; pp. 1170 - 1178
• Main Authors: Mburu, Gitau, Ayon, Sylvia, Mahinda, Samantha, Kaveh, Khoshnood
• Format: Journal Article
• Language: English
• Published: New York Springer US 01.09.2020; Springer; Springer Nature B.V
• Subjects: Adolescent; Adult; Drug use; Family planning; Female; Focus Groups; Gynecology; Harm Reduction; Health aspects; Health behavior; Humans; Interpersonal Relations; Interviews as Topic; Kenya; Maternal & child health; Maternal and Child Health; Medicine; Medicine & Public Health; Middle Aged; Pediatrics; Population Economics; Pregnancy; Pregnant women; Pregnant Women - ethnology; Pregnant Women - psychology; Public Health; Qualitative Research; Sexual Partners - psychology; Socioeconomic Factors; Sociology; Substance-Related Disorders - complications; Substance-Related Disorders - psychology; Womens health; Young Adult; Kenya; Pregnancy; Harm reduction; Maternal; Kenya; Drug use; Africa
• ISSN: 1092-7875; 1573-6628
• DOI: 10.1007/s10995-020-02910-w

Introduction Drug use during pregnancy can have negative effects on maternal and child health. However, there is a dearth of data regarding drug use among pregnant women in Kenya, where illicit drug use is on the rise. In this paper, we report factors influencing women’s decisions to use drugs during pregnancy. Methods In 2015, we conducted in-depth interviews and focus group discussions with 45 women who inject drugs and five key stakeholders involved in provision of services to people who use drugs in coastal Kenya. Inductive thematic analysis was conducted to draw out themes related to key determinants of drug use during pregnancy. Results Four key themes emerged outlining determinants of drug use during pregnancy: (i) the use of drugs to cope with the stress of unexpected pregnancy, (ii) the continued drug use during pregnancy to manage withdrawal, (iii) the dual effect of pregnancy on drug use either as a facilitator or as a moderator of drug use, and (iv) the role of male intimate partner in influencing women’s drug use during pregnancy. Conclusion Our paper reports women’s drug use during pregnancy and the factors influencing this phenomenon. To safeguard the health and well-being of pregnant women and their unborn children, there is a need for education and awareness raising, implementing couple-based harm reduction approaches to leverage on positive male influences, improving availability of drug treatment, and provision of family planning interventions for women who use drugs.